As of Jul 22
| +0.07 / +4.37%|
The 3 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +199.40% increase from the last price of 1.67.
The current consensus among 4 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.